RESUMO
Objetivo: Actualizar las recomendaciones sobre osteoporosis (OP) de la Sociedad Española de Reumatología (SER) basadas en la mejor evidencia posible. Métodos: Se creó un panel formado por nueve reumatólogos expertos en OP previamente seleccionados por la SER mediante una convocatoria abierta. Las fases del trabajo fueron: identificación de las áreas claves para la actualización del consenso anterior, análisis y síntesis de la evidencia científica (utilizando los niveles de evidencia del SIGN) y formulación de recomendaciones a partir de esta evidencia y de técnicas de consenso. Resultados: Esta revisión de las recomendaciones comporta una actualización en la evaluación diagnóstica de la OP y de su tratamiento. Propone unos criterios para considerar alto riesgo de fractura y unas indicaciones para iniciar tratamiento. Las recomendaciones abordan también cuestiones relativas a la seguridad de los tratamientos y al manejo de situaciones especiales como las enfermedades inflamatorias y el tratamiento con glucocorticoides. Conclusiones: Se presenta la actualización de las recomendaciones SER sobre OP
Objective: To update the recommendations on osteoporosis (OP) of the Spanish Society of Rheumatology (SER) based on the best possible evidence. Methods: A panel of nine expert rheumatologists in OP was created, previously selected by the SER through an open call. The phases of the work were: identification of the key areas for updating the previous consensus, analysis and synthesis of the scientific evidence (using the SIGN levels of evidence) and formulation of recommendations based on this evidence and consensus techniques. Results: This revision of the recommendations implies an update in the diagnostic evaluation and treatment of OP. It proposes some criteria to consider the high risk of fracture and some indications to start treatment. The recommendations also address issues related to the safety of treatments and the management of special situations such as inflammatory diseases and treatment with glucocorticoids. Conclusions: We present an update of SER recommendations on OP
Assuntos
Humanos , Osteoporose/diagnóstico , Osteoporose/terapia , Fraturas por Osteoporose/prevenção & controle , Conservadores da Densidade Óssea/uso terapêutico , Prática Clínica Baseada em Evidências , Segurança do Paciente , Glucocorticoides/uso terapêutico , DensitometriaRESUMO
OBJECTIVE: To update the recommendations on osteoporosis (OP) of the Spanish Society of Rheumatology (SER) based on the best possible evidence. METHODS: A panel of nine expert rheumatologists in OP was created, previously selected by the SER through an open call. The phases of the work were: identification of the key areas for updating the previous consensus, analysis and synthesis of the scientific evidence (using the SIGN levels of evidence) and formulation of recommendations based on this evidence and consensus techniques. RESULTS: This revision of the recommendations implies an update in the diagnostic evaluation and treatment of OP. It proposes some criteria to consider the high risk of fracture and some indications to start treatment. The recommendations also address issues related to the safety of treatments and the management of special situations such as inflammatory diseases and treatment with glucocorticoids. CONCLUSIONS: We present an update of SER recommendations on OP.
Assuntos
Osteoporose/diagnóstico , Osteoporose/terapia , HumanosRESUMO
OBJECTIVE: Due to increasing improvement in the diagnosis, evaluation and management of osteoporosis and the development of new tools and drugs, the Spanish Society of Rheumatology (SER) has promoted the development of recommendations based on the best evidence available. These recommendations should be a reference to rheumatologists and other health professionals involved in the treatment of patients with osteoporosis. METHODS: Recommendations were developed following a nominal group methodology and based on a systematic review. The level of evidence and degree of recommendation were classified according to the model proposed by the Center for Evidence Based Medicine at Oxford. The level of agreement was established through Delphi technique. Evidence from previous consensus and available clinical guidelines was used. RESULTS: We have produced recommendations on diagnosis, evaluation and management of osteoporosis. These recommendations include the glucocorticoid-induced osteoporosis, premenopausal and male osteoporosis. CONCLUSIONS: We present the SER recommendations related to the biologic therapy risk management.
Assuntos
Osteoporose , Absorciometria de Fóton , Densidade Óssea , Conservadores da Densidade Óssea/uso terapêutico , Feminino , Humanos , Masculino , Osteoporose/complicações , Osteoporose/diagnóstico , Osteoporose/tratamento farmacológico , Fraturas por Osteoporose/diagnóstico , Fraturas por Osteoporose/etiologia , Fraturas por Osteoporose/terapia , Fatores de Risco , EspanhaRESUMO
Objetivo: Evaluar el cumplimiento del tratamiento farmacológico de la osteoporosis en mujeres atendidas en el ámbito de la Atención Primaria (AP). En la osteoporosis, como en otras enfermedades crónicas, el fomento del tratamiento a largo plazo es fundamental. Pacientes y métodos: Se trata de un estudio observacional, descriptivo, transversal y multicéntrico, realizado en Centros de Salud de AP de las 17 Comunidades Autónomas. Se reclutaron 1.649 mujeres que habían iniciado tratamiento farmacológico para la osteoporosis al menos 3 meses antes. Para evaluar el cumplimiento se utilizaron dos cuestionarios: el test de Haynes-Sackett o de cumplimiento autocomunicado (CA) y el test de Morisky-Green (MG). Resultados: La edad media (± DE) de las pacientes era de 66,6 años (9,5) y el tiempo medio desde el diagnóstico era de 5,1 años (4,9). El tratamiento más prescrito fueron los bisfosfonatos (82% de las pacientes) y sólo un 52% recibía suplementos de calcio y vitamina D. El análisis del nivel de cumplimiento muestra que el 68,7% fue incumplidora según el test de MG, y el 11,2% fue incumplidora según el test de CA. Conclusiones: Un porcentaje importante de las mujeres con osteoporosis posmenopáusicas atendidas en AP en España presenta un elevado incumplimiento terapéutico (AU)
Objective: To assess therapeutic compliance in osteoporosis in women in a Primary Care (PC) setting. Patients and methods: Observational, descriptive, cross-sectional and multicenter study, conducted in PC centers of the 17 Spanish Autonomous Regions. 1,649women who had initiated treatment for osteoporosis at least 3 months before entering the study were recruited. To assess therapeutic compliance, two questionnaires, the Haynes-Sackett or self-communicated compliance test (AC) and the Morisky-Green test (MG) were used. Results: Patients mean age (±SD) was 66.59 years (9.5) and the mean time since diagnosis was 5.08 years (4.87). Bisphosphonates were the most precribed drugs (82% of the patients) and only 52% of the patients were taking calcium and vitaminDsupplements. Analysis of the therapeutic compliance level shows that, as per the MG test, 68.7% of the patients were non-compliers, and 11.2% were non-compliers as per the AC test. Conclusions: An important percentage ofwomenwith post-menopausal osteoporosis in Spains PC setting show a high level of non-compliance (AU)
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Osteoporose/complicações , Osteoporose/diagnóstico , Osteoporose/tratamento farmacológico , Difosfonatos/uso terapêutico , Cálcio/uso terapêutico , Vitamina D/uso terapêutico , Fatores de Risco , Atenção Primária à Saúde/métodos , Osteoporose Pós-Menopausa/tratamento farmacológico , Osteoporose Pós-Menopausa/prevenção & controle , Inquéritos e Questionários , Estudos Transversais/métodos , Antropometria/métodos , Modelos LogísticosRESUMO
OBJECTIVE: To assess therapeutic compliance in osteoporosis in women in a Primary Care (PC) setting. PATIENTS AND METHODS: Observational, descriptive, cross-sectional and multicenter study, conducted in PC centers of the 17 Spanish Autonomous Regions. 1,649 women who had initiated treatment for osteoporosis at least 3 months before entering the study were recruited. To assess therapeutic compliance, two questionnaires, the Haynes-Sackett or self-communicated compliance test (AC) and the Morisky-Green test (MG) were used. RESULTS: Patients' mean age (± SD) was 66.59 years (9.5) and the mean time since diagnosis was 5.08 years (4.87). Bisphosphonates were the most precribed drugs (82% of the patients) and only 52% of the patients were taking calcium and vitamin D supplements. Analysis of the therapeutic compliance level shows that, as per the MG test, 68.7% of the patients were non-compliers, and 11.2% were non-compliers as per the AC test. CONCLUSIONS: An important percentage of women with post-menopausal osteoporosis in Spain's PC setting show a high level of non-compliance.
Assuntos
Conservadores da Densidade Óssea/uso terapêutico , Adesão à Medicação/estatística & dados numéricos , Osteoporose Pós-Menopausa/tratamento farmacológico , Idoso , Cálcio/uso terapêutico , Estudos Transversais , Difosfonatos/uso terapêutico , Feminino , Humanos , Pessoa de Meia-Idade , Atenção Primária à Saúde , Inquéritos e Questionários , Vitamina D/uso terapêuticoRESUMO
Objetivo Describir las características clínicas y epidemiológicas de los sujetos incluidos en el Registro Nacional de Paget. Sujetos y método Registro de pacientes con enfermedad ósea de Paget (EOP), confirmada radiológicamente, de 25 centros participantes. Se recogieron datos clínico epidemiológicos (edad, sexo, fecha y manifestaciones al diagnóstico y tratamientos), calidad de vida (CV) (cuestionario EuroQol de 5 dimensiones), estado de salud, factores ambientales (profesión, antecedentes de sarampión, contacto con animales, consumo de lácteos, condiciones de la vivienda, lugar de nacimiento y domicilio) y familiares (historia de EOP, procedencia de los ascendientes y número de hijos). Se realizó una descripción estadística de los datos. Resultados El registro incluyó a 602 sujetos con edad media de 62 ± 11 años con predominio de varones (55%). El 79% de los sujetos presentaba síntomas en el momento del diagnóstico, fundamentalmente dolor (83%). El 82% de los sujetos había recibido tratamiento, principalmente bisfosfonatos, con más de un fármaco en el 47% de los casos. A pesar del tratamiento, una proporción importante tenía limitación de la CV, especialmente relacionada con dolor (64%), movilidad (47%) y ansiedad junto con malestar (33%). La mayor parte de los sujetos habían estado expuestos a situaciones que se consideran factores de riesgo. El 14% de los sujetos tenía historia familiar de EOP y el 1,5% de los sujetos tenía hijos con EOP. Los ascendientes de los casos familiares procedían con más frecuencia de Ávila, Salamanca, Málaga y La Coruña. Conclusiones El dolor y la limitación de la movilidad disminuyen la CV del sujeto con EOP a pesar del tratamiento. Son frecuentes los antecedentes de exposición a factores de riesgo (AU)
Objectives To describe the clinical and epidemiological characteristics of patients included in the National Register of Paget's disease. Methods A Register of patients with Paget disease (PD), radiologically confirmed, and pertaining to 25 hospitals was analysed. Clinical and epidemiological data were collected, including age, sex, date and presentations at time of diagnosis, treatment, quality of life (QL) (EuroQol 5D) and perceived health, environmental factors (profession, history of measles, contact with animals, dairy consumption, housing conditions, place of birth and address) and family history (PD history, origin of the ancestors, number of children). We conducted a statistical description of the data. Results The register included 602 patients with an average age of 62±11 years and a predominance of male (55%). Of the patients included, 79% showed symptoms at the time of diagnosis, mainly pain (83%); 82% had received treatment, mainly bisphosphonates (47% more than one drug). Despite treatment, a significant proportion had limitations in their QL, especially related to pain (64%), mobility (47%) and anxiety/depression (33%). Most of the patients had been exposed to situations which were considered as risk factors. Of the patients included, 14% had family history of PD and 1.5% had children with PD. The ancestors of the familial cases came more frequently from Avila, Salamanca, La Coruña and Malaga. Conclusions The pain and the limitation of mobility decrease the QL of patients with PD despite treatment. Frequently, patients have a history of exposure to risk factors (AU)
Assuntos
Humanos , Osteíte Deformante/epidemiologia , Espanha/epidemiologia , Registros de Doenças , Predisposição Genética para Doença , Fatores de RiscoRESUMO
OBJECTIVES: To describe the clinical and epidemiological characteristics of patients included in the National Register of Paget's disease. METHODS: A Register of patients with Paget disease (PD), radiologically confirmed, and pertaining to 25 hospitals was analysed. Clinical and epidemiological data were collected, including age, sex, date and presentations at time of diagnosis, treatment, quality of life (QL) (EuroQol 5D) and perceived health, environmental factors (profession, history of measles, contact with animals, dairy consumption, housing conditions, place of birth and address) and family history (PD history, origin of the ancestors, number of children). We conducted a statistical description of the data. RESULTS: The register included 602 patients with an average age of 62±11 years and a predominance of male (55%). Of the patients included, 79% showed symptoms at the time of diagnosis, mainly pain (83%); 82% had received treatment, mainly bisphosphonates (47% more than one drug). Despite treatment, a significant proportion had limitations in their QL, especially related to pain (64%), mobility (47%) and anxiety/depression (33%). Most of the patients had been exposed to situations which were considered as risk factors. Of the patients included, 14% had family history of PD and 1.5% had children with PD. The ancestors of the familial cases came more frequently from Avila, Salamanca, La Coruña and Malaga. CONCLUSIONS: The pain and the limitation of mobility decrease the QL of patients with PD despite treatment. Frequently, patients have a history of exposure to risk factors.